Pfizer and BioNTech seek full FDA approval of coronavirus vaccine in US
by Lauren Aratani in New York from US news | The Guardian on (#5HJBE)
Application for full approval will only include people 16 and older while over 170m doses have already been delivered across US
The Pfizer/BioNTech pharmaceutical partnership has started an application for full approval of its Covid-19 vaccine with the US Food and Drug Administration (FDA), the companies announced Friday.
More than 170m doses of the vaccine have been delivered across the US since it was approved for emergency use authorization in December, the first Covid-19 vaccine to receive the authorization from the FDA.
Continue reading...